SCABENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Scabene, and what generic alternatives are available?
Scabene is a drug marketed by Stiefel and is included in two NDAs.
The generic ingredient in SCABENE is lindane. There are two drug master file entries for this compound. Additional details are available on the lindane profile page.
Summary for SCABENE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 199 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SCABENE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SCABENE
US Patents and Regulatory Information for SCABENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stiefel | SCABENE | lindane | LOTION;TOPICAL | 086769-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Stiefel | SCABENE | lindane | SHAMPOO;TOPICAL | 087940-001 | Apr 8, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |